Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedJul 17, 2024
DataAggregated Company Financials
Companies60
  • 7D3.2%
  • 3M-0.4%
  • 1Y0.7%
  • YTD-5.4%

In the last week, the Medical Equipment industry is up 3.2%, with Xvivo Perfusion up 23%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 25% per annum.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 17 Jul 2024SEK 165.6bSEK 73.1bSEK 2.7b30.8x62.2x2.3x
Fri, 14 Jun 2024SEK 161.6bSEK 72.8bSEK 2.6b30.2x61.3x2.2x
Sun, 12 May 2024SEK 169.7bSEK 73.0bSEK 2.7b31.8x61.8x2.3x
Tue, 09 Apr 2024SEK 170.9bSEK 72.2bSEK 2.6b32.3x66.6x2.4x
Thu, 07 Mar 2024SEK 159.0bSEK 72.2bSEK 2.4b32.4x65.9x2.2x
Sat, 03 Feb 2024SEK 166.4bSEK 73.1bSEK 1.9b46.4x89.9x2.3x
Mon, 01 Jan 2024SEK 173.8bSEK 71.4bSEK 1.5b41x113.4x2.4x
Wed, 29 Nov 2023SEK 164.3bSEK 70.0bSEK 1.3b35.3x129.3x2.3x
Fri, 27 Oct 2023SEK 137.2bSEK 69.2bSEK 1.1b25.1x123.5x2x
Sun, 24 Sep 2023SEK 150.3bSEK 68.8bSEK 1.1b31.3x140.6x2.2x
Tue, 22 Aug 2023SEK 154.3bSEK 68.2bSEK 826.9m30.2x186.7x2.3x
Thu, 20 Jul 2023SEK 160.8bSEK 68.0bSEK 292.1m33.6x550.4x2.4x
Sat, 17 Jun 2023SEK 179.9bSEK 67.0bSEK 1.3b34.3x133.9x2.7x
Mon, 15 May 2023SEK 178.0bSEK 65.8bSEK 1.4b37.1x126.5x2.7x
Wed, 12 Apr 2023SEK 177.2bSEK 64.1bSEK 1.4b37.3x130.4x2.8x
Fri, 10 Mar 2023SEK 168.6bSEK 64.1bSEK 1.4b38.6x117.7x2.6x
Sun, 05 Feb 2023SEK 183.7bSEK 62.7bSEK 2.0b33.3x92.8x2.9x
Tue, 03 Jan 2023SEK 161.8bSEK 61.8bSEK 2.3b27.3x69.8x2.6x
Thu, 01 Dec 2022SEK 170.2bSEK 61.8bSEK 2.4b28.6x71.2x2.8x
Sat, 29 Oct 2022SEK 164.1bSEK 60.9bSEK 2.7b24.2x60.1x2.7x
Mon, 26 Sep 2022SEK 148.3bSEK 59.7bSEK 2.8b25.9x53.8x2.5x
Wed, 24 Aug 2022SEK 173.9bSEK 58.8bSEK 2.7b33.5x63.8x3x
Fri, 22 Jul 2022SEK 184.5bSEK 58.8bSEK 2.6b33.8x69.8x3.1x
Sun, 19 Jun 2022SEK 182.4bSEK 58.4bSEK 3.0b35x61.7x3.1x
Tue, 17 May 2022SEK 212.2bSEK 57.5bSEK 2.9b52x72.9x3.7x
Thu, 14 Apr 2022SEK 248.0bSEK 56.9bSEK 3.1b62.9x79.8x4.4x
Sat, 12 Mar 2022SEK 234.3bSEK 56.9bSEK 3.1b56.6x75.5x4.1x
Mon, 07 Feb 2022SEK 272.6bSEK 56.3bSEK 3.6b56.7x75x4.8x
Wed, 05 Jan 2022SEK 303.9bSEK 56.9bSEK 3.8b60.6x79x5.3x
Fri, 03 Dec 2021SEK 294.6bSEK 56.9bSEK 3.8b55.8x76.8x5.2x
Sun, 31 Oct 2021SEK 297.3bSEK 56.3bSEK 3.9b75.3x76.4x5.3x
Tue, 28 Sep 2021SEK 292.9bSEK 57.8bSEK 4.4b79.3x66.2x5.1x
Thu, 26 Aug 2021SEK 299.0bSEK 57.8bSEK 4.4b71.7x67.3x5.2x
Price to Earnings Ratio

72x


Total Market Cap: SEK 319.9bTotal Earnings: SEK 4.4bTotal Revenue: SEK 57.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 90x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 62.2x which is lower than its 3-year average PE of 90.0x.
  • The 3-year average PS ratio of 3.2x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have declined 16% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market2.99%
Healthcare2.62%
Medical Equipment3.20%
Medical Supplies10.43%
Medical Equipment1.18%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 65.7x.
    • Analysts are expecting annual earnings growth of 16.9%, which is lower than the prior year's growth of 39.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 52% over the next 5 years.
  • However this is lower than its past earnings growth rate of 344% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 17% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
XVIVO Xvivo PerfusionSEK 512.0022.8%
+SEK 3.0b
73.6%PE133.6x
GETI B GetingeSEK 185.352.0%
+SEK 980.5m
-4.1%PE22.1x
EKTA B ElektaSEK 66.801.8%
+SEK 458.5m
-20.2%PE19.6x
VIMIAN Vimian GroupSEK 35.902.3%
+SEK 417.9m
32.6%PE204.7x
CEVI CellaVisionSEK 270.003.4%
+SEK 214.7m
43.2%PE45.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BACTI B

SEK 72.00

Bactiguard Holding

7D

6.8%

1Y

6.2%

CARE

SEK 35.50

Careium

7D

17.2%

1Y

116.5%

XVIVO

SEK 512.00

Xvivo Perfusion

7D

22.8%

1Y

73.6%

QLINEA

SEK 3.60

Q-linea

7D

-7.9%

1Y

20.6%

IMP A SDB

SEK 36.75

Implantica

7D

-2.9%

1Y

107.6%

EKTA B

SEK 66.80

Elekta

7D

1.8%

1Y

-20.2%

GETI B

SEK 185.35

Getinge

7D

2.0%

1Y

-4.1%

SUS

SEK 126.70

Surgical Science Sweden

7D

-1.2%

1Y

-43.8%

VIMIAN

SEK 35.90

Vimian Group

7D

2.3%

1Y

32.6%

PRLD

SEK 0.27

Prolight Diagnostics

7D

-27.8%

1Y

-84.2%

DIGN

SEK 1.48

Dignitana

7D

-20.4%

1Y

-63.0%

INTEG B

SEK 53.20

Integrum

7D

-7.3%

1Y

204.3%

ARCOMA

SEK 16.50

Arcoma

7D

-5.7%

1Y

70.1%